EricMReimanMD
Psychiatry • Phoenix, AZExecutive Director of the Banner Alzheimer’s Institute and Chief Executive Officer for Banner Research. Professor of Psychiatry at the University of Arizona. Professor of Neuroscience at Arizona State University. Clinical Director of Neurogenomics at the Translational Genomics Research Institute. Director of the Arizona Alzheimer’s Consortium.
Are you Dr. Reiman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 66 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
925 E Mcdowell Rd
4th Floor
Phoenix, AZ 85006Phone+1 602-239-6800Fax+1 602-239-6988
Summary
- Dr. Eric Reiman, MD is a board certified psychiatrist in Phoenix, Arizona. He is currently licensed to practice medicine in Arizona.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Psychiatry, 1983 - 1983
Duke University HospitalResidency, Psychiatry, 1980 - 1983
Duke University School of MedicineClass of 1980
Certifications & Licensure
AZ State Medical License 1988 - 2026- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Clinical Evaluation of Florbetapir F 18 (18F-AV-45) Start of enrollment: 2009 Dec 01
Publications & Presentations
PubMed
- X-chromosome-wide association study for Alzheimer's disease.Julie Le Borgne, Lissette Gomez, Sami Heikkinen, Najaf Amin, Shahzad Ahmad
Molecular Psychiatry. 2024-12-04 - Reversibility of cognitive worsening observed with BACE inhibitor umibecestat in the Alzheimer's Prevention Initiative (API) Generation Studies.Pierre N Tariot, Marie-Emmanuelle Riviere, Stephen Salloway, Jeffrey M Burns, Jón G Snaedal
Alzheimer's & Dementia. 2024-11-01 - 1 citationsHeparin treatment is associated with a delayed diagnosis of Alzheimer's dementia in electronic health records from two large United States health systems.Benjamin Readhead, Eyal Klang, Undina Gisladottir, Maxence Vandromme, Li Li
Molecular Psychiatry. 2024-10-08
Press Mentions
Heart Diseases Raise Dementia Risk: Could a Common Blood Thinner Lower It?October 16th, 2024- Francisco Lopera, Pioneer in Alzheimer’s Research, Dies at 73September 10th, 2024
- Mutation Protected Man from Alzheimer’s Disease, Hinting at TreatmentMay 15th, 2023
- Join now to see all
Grant Support
- PET, APOE &The Preclinical Course Of Alzheimer'S DiseaseNational Institute On Aging2008–2012
- Neuropathology CoreNational Institute On Aging2011
- Education And Information Transfer CoreNational Institute On Aging2011
- Data Management And Statistics CoreNational Institute On Aging2011
- Clinical CoreNational Institute On Aging2011
- Administrative CoreNational Institute On Aging2011
- Arizona Alzheimer'S Disease Core CenterNational Institute On Aging2001–2011
- The GE Pettrace Cyclotron: A Scientific Resource For The State Of ArizonaNational Center For Research Resources2010
- Cyclotron, PET And MRI Facility Improvement: A Scientific Resource For ArizonaNational Center For Research Resources2010
- PET, APOE &The Preclinical Course Of Alzheimer DiseaseNational Institute Of Mental Health2003–2006
- PET, APOE, &The Preclinical Course Of Alzheimer DiseaseNational Institute Of Mental Health1998–2002
- Application Of PET To The Study Of Psychiatric DisordersNational Institute Of Mental Health1985–1988
